Metastasis-Free Survival, but Not Biochemical Failure, is a Strong Surrogate Endpoint for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 Conference

Jackson, WC, Tang, M, Schipper, M et al. (2020). Metastasis-Free Survival, but Not Biochemical Failure, is a Strong Surrogate Endpoint for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), S63-S64.

cited authors

  • Jackson, WC; Tang, M; Schipper, M; Sandler, HM; Zumsteg, ZS; Efstathiou, JA; Shipley, WU; Seiferheld, W; Lukka, H; Bahary, JP; Zietman, AL; Pisansky, TM; Zeitzer, KL; Hall, WA; Dess, RT; Lovett, RD; Balogh, A; Feng, FY; Spratt, DE

authors

date/time interval

  • October 25, 2020 -

publication date

  • November 1, 2020

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • ELECTR NETWORK

Conference

  • 62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • S63

end page

  • S64

volume

  • 108

issue

  • 3